Finance
Markets

BDX

stock Healthcare Medical Instruments & Supplies
Becton Dickinson
$150.65 -3.18 (-2.07%) Delayed · quoted 6d ago
Mixed 41% Steady

What the indicators say

Mixed 2 of 5 trend signals bullish
Momentum · RSI 14 Neutral
50
0oversold 30overbought 70100

RSI 50 — momentum is balanced between buyers and sellers.

EMA 21 $151.09
Below
Near-term trend is down
SMA 50 $148.27
Above
Medium-term trend is up
SMA 200 $154.15
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $145.32
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jul 14

The day open and close within the day's range
Low $148.46 High $151.93
Open
$151.83
-1.30%
Close
$150.65
-2.07%
52-week range where the price sits across its year
52w low $126.90 52w high $187.35
Current
$150.65
Prev close
$153.83
Volume 0.66× the 3-month average
0 avg 2× avg
Today
1.91M
3-mo avg
2.91M

Earningscalendar synced from Yahoo 57d ago

Most recent
May 775 days ago
Next expected
Aug 6in 16 days

Recent earnings dates

  • May 7 75 days ago
  • Apr 2 110 days ago
  • Feb 9 162 days ago
  • Nov 6, 2025 257 days ago

Past earnings dates come from BDX’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Fair

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), BDX’s fundamentals read as fair overall.

P/E ratio Fair
38.2x

At 38.2x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Strong
2.76%

A 2.8% yield is a healthy, generally sustainable level of cash income.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
7.7%

A 7.7% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
6.6%

A 6.6% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
3.0%

A 3.0% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data
—

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Fair
1.11

At 1.11, short-term assets cover short-term bills with a little room to spare.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+8.2%

Revenue grew 8.2% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-1.6%

Net income fell 1.6% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $19.1B$18.9B$19.4B$20.2B$21.8B
Net income $2.1B$1.8B$1.5B$1.7B$1.7B
Diluted EPS $6.85$5.88$4.94$5.86$5.82
Dividend / share $3.32$3.48$3.64$3.80$4.16
Total assets $53.9B$52.9B$52.8B$57.3B$55.3B
Total liabilities —————
Shareholder equity $23.7B$25.3B$25.8B$25.9B$25.4B

Leadershipsynced from SEC 58d ago

  • Roque Vitor EVP & Chief Financial Officer
  • Feld Michael EVP, Chief Revenue Officer
  • Minnix Lanesha EVP and General Counsel
  • Neal Shana Carol EVP and Chief People Officer
  • Spikner Pamela L. SVP Controller & CAO
  • Urbini Massimiliano EVP & Chief ISC Officer
  • Brown William M Director
  • Byington Carrie L Director
  • Eckert R Andrew Director
  • Hayes Gregory Director
  • Henderson Jeffrey William Director
  • Huffines Robert Luther Director
  • Jones Christopher Ian Montague Director
  • Ring Timothy M Director
  • Scott Bertram L Director
  • Waldstreicher Joanne Director
  • Wright Jacqueline Director

Officers and board are drawn from BDX’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$3.28
2026 so far
$1.051 payment
2026 projected
$4.20+28.1% vs 2025

Projection scales BDX’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Mar 10 $1.05
  • Dec 8, 2025 $0.83
  • Sep 8, 2025 $0.82
  • Jun 9, 2025 $0.82
  • Mar 10, 2025 $0.82
  • Dec 9, 2024 $0.82
  • Sep 9, 2024 $0.75
  • Jun 10, 2024 $0.75
  • Mar 7, 2024 $0.75
  • Dec 7, 2023 $0.75
  • Sep 7, 2023 $0.72
  • Jun 8, 2023 $0.72
  • Mar 9, 2023 $0.72
  • Dec 8, 2022 $0.72
  • Sep 8, 2022 $0.68
  • Jun 8, 2022 $0.68
  • Mar 9, 2022 $0.67
  • Dec 9, 2021 $0.67
  • Sep 8, 2021 $0.64
  • Jun 8, 2021 $0.64

Recent SEC filingssynced from SEC 51d ago

© 2026 Isaac Bythewood · Some rights reserved